[HTML][HTML] COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies

R Raman, KJ Patel, K Ranjan - Biomolecules, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options

S Choudhary, K Sharma, O Silakari - Microbial pathogenesis, 2021 - Elsevier
Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric …

UM Geisen, DK Berner, F Tran, M Sümbül… - Annals of the …, 2021 - ard.bmj.com
Introduction In light of the SARS-CoV-2 pandemic, protecting vulnerable groups has become
a high priority. Persons at risk of severe disease, for example, those receiving …

[HTML][HTML] Musculoskeletal involvement of COVID-19: review of imaging

SL Ramani, J Samet, CK Franz, C Hsieh, CV Nguyen… - Skeletal Radiology, 2021 - Springer
The global pandemic of coronavirus disease 2019 (COVID-19) has revealed a surprising
number of extra-pulmonary manifestations of severe acute respiratory syndrome coronavirus …

[HTML][HTML] A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection

DA Jamison Jr, S Anand Narayanan… - European Journal of …, 2022 - nature.com
COVID-19, the disease caused by SARS-CoV-2, has claimed approximately 5 million lives
and 257 million cases reported globally. This virus and disease have significantly affected …

[HTML][HTML] Viral infections, the microbiome, and probiotics

A Harper, V Vijayakumar, AC Ouwehand… - Frontiers in Cellular …, 2021 - frontiersin.org
Viral infections continue to cause considerable morbidity and mortality around the world.
Recent rises in these infections are likely due to complex and multifactorial external drivers …

The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune …

CA Cañas - Medical Hypotheses, 2020 - Elsevier
With the progression of the COVID-19 pandemic, there have been different reports about the
development of autoimmune diseases once the infection is controlled. After entering the …

[HTML][HTML] The role of Interleukin 6 inhibitors in therapy of severe COVID-19

E Nasonov, M Samsonov - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …

Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19

S Tuzun, A Keles, T Yildiran, D Palamar - 2020 - researchsquare.com
Abstract IMPORTANCE Coronavirus disease 2019 (COVID-19) is an emerging disease that
was declared as a pandemic by WHO. Although there are many retrospective studies to …

[HTML][HTML] A review of cytokine-based pathophysiology of Long COVID symptoms

RN Low, RJ Low, A Akrami - Frontiers in Medicine, 2023 - frontiersin.org
The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …